Prebiotic EffecT InfanTs
PETIT
Double-blind, Randomized Placebo-controlled Trial Investigating the Effect of Prebiotic Inulin-type Fructans on Bowel Habits of Infants
1 other identifier
interventional
140
1 country
2
Brief Summary
The study aims to confirm the effectiveness of chicory-derived prebiotic inulin-type fructans on stool consistency in infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedStudy Start
First participant enrolled
March 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 12, 2023
April 1, 2023
3.2 years
March 5, 2021
April 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stool consistency
Assessed by the parents in a continuous daily bowel diary over the study period
4 weeks
Secondary Outcomes (10)
Stool frequency
4 weeks
Stool colour
4 weeks
Stool amount
4 weeks
Sleep
4 weeks
Stool pH
4 weeks
- +5 more secondary outcomes
Study Arms (2)
Prebiotic
EXPERIMENTALInulin-type fructans
Placebo
PLACEBO COMPARATORMaltodextrin
Interventions
Eligibility Criteria
You may qualify if:
- Child is healthy at the time of pre-examination
- Child was born on term or preterm (≥ 32 weeks of gestation)
- Child is aged 6-12 months at the time of pre-examination (for preterm born children (32-37 weeks of gestation), corrected age will be applied)
- Normal growth (weight and length for age between 10th and 90th percentiles, Fenton and Kim 2013)
- Child receives at least one meal per day as complementary feeding
- Child and legal guardian are able and willing to follow the study instructions
- Child is suitable for participation in the study according to the investigator/physician/study personnel
- Written informed consent is given by parent or legal guardian
You may not qualify if:
- No legal guardian's command of any local language
- Organic causes of defecation disorders incl. Hirschsprung disease, Spina bifida, hypothyroidism etc.
- Other metabolic or renal abnormalities or psychomotor retardation (e.g. hypotonia)
- Child has allergy to cow's milk protein or lactose intolerance
- Child has been or is currently breast-fed more than once daily (6 weeks before intervention)
- Child has mostly loose or watery stools in ≥ 50% of defecations
- Use of drugs (e.g. antibiotics) influencing gastrointestinal function (6 weeks before intervention)
- Use of laxatives or pre- or probiotic supplements in the previous 4 weeks before intervention
- Child is currently involved or will be involved in another clinical or food study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beneo-Institutelead
- Hospital Universitari Sant Joan de Reuscollaborator
- Hospital de Tarragona Joan XXIIIcollaborator
- Institut Investigacio Sanitaria Pere Virgilicollaborator
Study Sites (2)
Hospital Universitari Sant Joan de Reus - Magatzem
Reus, 43204, Spain
Hospital Universitari Joan XXIII de Tarragona - Almacén general
Tarragona, 43005, Spain
Related Publications (1)
Closa-Monasterolo R, Ferre N, Castillejo-DeVillasante G, Luque V, Gispert-Llaurado M, Zaragoza-Jordana M, Theis S, Escribano J. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study. Int J Food Sci Nutr. 2017 Aug;68(5):587-594. doi: 10.1080/09637486.2016.1263605. Epub 2016 Dec 8.
PMID: 27931142BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ricardo Closa Monasterolo, Phd, MD
Paediatrics Unit, University Hospital Joan XXIII, Tarragona, Spain. Paediatrics Research Unit on Nutrition and Human Development, Universitat Rovira i Virgili, Reus, Spain
- PRINCIPAL INVESTIGATOR
Joaquin Escribano Subias, PhD, MD
Paediatrics Unit, University Hospital Sant Joan, Reus, Spain. Paediatrics Research Unit on Nutrition and Human Development, Universitat Rovira i Virgili, Reus, Spain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2021
First Posted
March 10, 2021
Study Start
March 17, 2021
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
April 12, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share